https://www.selleckchem.com/products/eg-011.html
Here, we aim to analyze the most recent evidence regarding the possible crosstalk between prostate, microbiome, and inflammation.Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticancer effect of C-mab combined with PTX on oral SCC cells in vitro. We used two oral SCC cells (HSC4, OSC19) and A431 cells. PTX alone inhibited cell growth in all cel
Like
Comment
Share
